baber/WOPTO huggingface dataset:
Patent NZ-228552-A (NZ)
Title: Vehicle inspection trailer with brake, steering and suspension testing areas
Inventor: VAUGHAN RODNEY GEORGE
IPC: B62D63/06
Filed: 1989-03-30
Abstract: A mobile vehicle inspection facility (10) which is provided with a towing hitch (12) to enable the facility (10) to be towed by a prime mover. The facility (10) includes a brake testing assembly (27) which provides an indication of the condition of the brakes of a vehicle being tested. The brake testing assembly (27) also incorporates load cells (60) which provide a signal indicative of the weight carried by the wheels being tested. The facility (10) further includes a steering and suspension play detection assembly (36) which is used to determine the play in the steering and suspension of the vehicle. The brake testing assembly (27) and the steering and suspension play detection assembly (36) are aligned transversely of the facility (10) so that a vehicle being tested may move transversely of the facility (10) between the brake testing assembly (27) and the steering suspension play detection assembly (36). The facility (10) has wheel assemblies (13) which are movable from a transport position supporting the facility (10), to an inoperative position allowing the test vehicle to move transversely of the facility (10).
Patent NZ-229635-A (NZ)
Title: Fire and smoke protective hood includes a layer of titanium on its outer surface
Inventor: MCKENZIE NOEL ROBERTSON
IPC: B32B27/08
Filed: 1989-06-20
Abstract: A protective hood for protecting an individual from the effects of fire and smoke in a fire related emergency comprises a high temperature resistant plastics material having a layer of titanium on at least a part of its outer surface. Preferably the plastics material has a layer of fluoropolymer on its inner suface and the titanium is sufficiently thick to provide the required heat reflective properties but is transparent to visible light.
Patent NZ-234225-A (NZ)
Title: Antibiotic from zalerion arboricola and its use as an antifungal agent and antipneumocystis agent
Inventor: SCHWARTZ ROBERT E
IPC: A61P31/04
Filed: 1990-06-25
Abstract: An antibiotic agent produced by the cultivation of Zalerion arboricola which is a cyclic lipopeptide with very high activity against human pathogens and of very low mammalian toxicity and its production, isolation, and use are described.
Patent NZ-240099-A (NZ)
Title: Printing blanket with stabilising layer having continuous multifilament synthetic warp yarns
Inventor: O'RELL DENNIS DEE
IPC: B41N10/04
Filed: 1991-10-04
Abstract: The present invention relates to improved compressible, offset printing blankets suitable for use on high speed web processors. These blankets have improved resistance to fall-off at the gap and also have improved resistance to surface piping subsequent to reverse rolling of the blanket. The instant printing blanket comprises a carcass layer, a compressible layer overlaying the carcass layer, a stabilizing layer overlaying the compressible layer and an ink transfer layer upon the compressible layer, wherein the stabilizing layer is formed of a fabric having a plurality of continuous filament synthetic warp yarns, preferably nylon or polyester, following a sinusoidal path over and under the weft yarns. <IMAGE>
Patent NZ-241560-A (NZ)
Title: Beta-1,4-galactanase, dna, recombinant production and preparations for degrading cell walls
Inventor: DORREICH KURT
IPC: C12R1/66
Filed: 1992-02-07
Abstract: A partial amino acid sequence of a  beta -1,4-galactanase obtainable by means of Aspergillus aculeatus is described, and also a corresponding recombinant DNA sequence, vector and transformed host. Use of the  beta -1,4-galactanase or a pectinase preparation enriched with the  beta -1,4-galactanase for degradation or modification of plant cell walls is described.
Patent NZ-254917-A (NZ)
Title: Complex catalysts containing transition metals and their use in preparing epoxides
Inventor: BELL DAVID
IPC: C07D307/22
Filed: 1993-08-05
Abstract: PCT No. PCT/GB93/01666 Sec. 371 Date Oct. 6, 1993 Sec. 102(e) Date Oct. 6, 1993 PCT Filed Aug. 5, 1993 PCT Pub. No. WO94/03271 PCT Pub. Date Feb. 17, 1994A compound of formula (I):    <IMAGE>  (I)  n which M is a transition metal ion; A is a counter-ion if required; r, s and t are independently 0 to 3 such that r+s+t is in the range of 1 to 3; Ra, Rb, Rc are each independently hydrogen or CH2OR' where R' is hydrogen or an organic group; B and E are independently oxygen, CH2, NRd in which Rd is alkyl, hydrogen, alkylcarbonyl, or arylcarbonyl or SOn where n is 0 or an integer 1 or 2, with the proviso that B and E are not simultaneously CH2 and that when B is oxygen, NRd or SOn, then r cannot be 0, and when E is oxygen, NRd or SOn, then t cannot be 0; R1, R2, R3, R4, R5, R6, R7, R8, R9 and R10 are independently hydrogen, alkyl or alkoxy.
Patent NZ-265305-A (NZ)
Title: Process for preparing beta-lactams
Inventor: BOURZAT JEAN-DOMINIQUE
IPC: C07D417/04
Filed: 1994-04-14
Abstract: A method for preparing 3-hydroxy (3R,4S)-2-azetidinones of general formula (Ia), and the use thereof for preparing taxoids, are disclosed. In general formula (Ia), Ar is an aryl radical.
Patent NZ-290448-A (NZ)
Title: Two component vector surface expression of enzyme in gene directed prodrug therapy therefor
Inventor: SPRINGER CAROLINE JOY
IPC: A61K35/76
Filed: 1995-07-27
Abstract: The invention provides a two component system for use in association with one another comprising:   (a) a vector capable of expressing an enzyme at the surface of a cell; and (b) a prodrug which can be converted into an active drug by said enzyme, useful in the treatment of tumours.
Patent NZ-305594-A (NZ)
Title: Diltiazem hydrochloride controlled release formulations
Inventor: CHEN CHIH-MING
IPC: A61K9/50
Filed: 1996-03-13
Abstract: A once-a-day controlled release diltiazem formulation is described which includes: (a) from 20 to 50% by weight of enteric polymeric membrane coated pellets comprising a polymer membrane coated core which comprises a biologically inert core which is coated with a first layer which consists essentially of diltiazem and a polymeric binder; and a second layer which comprises a membrane comprising a pH dependent polymeric material; and (b) from 50% to 80% by weight of delayed pulse polymeric membrane coated pellets comprising a polymeric membrane coated core which comprises a biologically inert core which is coated with a first layer which consists essentially of diltiazem and a polymeric binder and a second layer which comprises a polymeric membrane which will substantially maintain its integrity in the varying pH conditions of the gastrointestinal tract but is permeable to diltiazem; and (c) a unit dose containment system.
Patent NZ-316545-A (NZ)
Title: Lap-top computer comprising a keyboard and screen has loudspeakers with transducers mounted thereon
Inventor: AZIMA HENRY
IPC: G06F1/16
Filed: 1996-09-02
Abstract: The lap-top computer has a keyboard and display screen. The screen is or forms part of a distributed mode acoustic radiator loudspeaker which is hinged to the display screen. The speaker radiators comprise a stiff lightweight panel with cellular core sandwiched by opposing skin layers. The loudspeaker has a transducer mounted wholly and exclusively on it to vibrate the radiator causing it to resonate to produce an acoustic output. The loudspeakers are each housed in a slot in the display screen housing for sliding movement between a stored position where they are substantially in the slot and a use position where they are on opposite sides of the display screen.
Patent NZ-324479-A (NZ)
Title: Linear block polymer comprising urea and urethane groups, method for the production of linear block polymers and use of the block polymers as implants
Inventor: FLODIN PER
IPC: C08G18/67
Filed: 1996-11-25
Abstract: Linear block polymer having a molecular weight of at least 104 Dalton, comprising urea and urethane groups and ester groups at such a distance from each other that after hydrolysis of these ester groups fragments are created which are so small that they are biologically degradable and can be excreted from a human body and further including an end group selected from primary NH2 and OH groups, which can be substituted by a monoamine. The polymers are intended to be used as implants.
Patent NZ-330244-A (NZ)
Title: Isoxazole derivatives useful in the treatment of inflammatory diseases
Inventor: NAKATSUKA MASASHI
IPC: C07D261/14
Filed: 1998-04-21
Abstract: escribed is an isoxzole derivative of formula I. The derivatives are useful as antiinflammatory agents.
Patent NZ-331231-A (NZ)
Title: Joinery  construction  for  mounting  glazing  panels includes an elongate element to infill a recess between  one side of a glazing panel and an opposing abutment
Inventor: BAINES IAN PAUL
IPC: E06B7/12
Filed: 1998-07-31
Abstract: A   joinery   construction   adapted   for   mounting predetermined  single  and  multiple  panels,  said  joinery construction including at least one frame portion  having  a primary  recess  which  has opposingly  arranged  first  and second  abutment  portions, an optional  independent  infill member  adapted  to be positionable in the  primary  recess, said  infill  member  when engaged with  the  frame  portion forming a secondary recess and a third abutment portion; and at  least  one  panel positionable in the secondary  recess, said  panel  secured  between the first and  third  abutment portions;  wherein the joinery construction is adaptable  to accommodate  multiple  panels by  removal  of  the  optional independent   infill   member.   Claims   for   methods   of constructing joinery are also included.
Patent NZ-331514-A (NZ)
Title: A silica based bioactive glass composition having a particle size range less than 90 microns that can be used in conjunction with a delivery agent e.g. toothpaste to release Ca and P from the silica particles and methods of treatment using bioactive glass
Inventor: LITKOWSKI LEONARD J
IPC: A61K6/06
Filed: 1997-01-29
Abstract: A silica-based bioactive glass composition that can be used in conjunction with a delivery agent such as a toothpaste, gel, etc., having a particle size range < 90 µm which will form a rapid and continuous reaction with body fluids due to the immediate and long-term ionic release of Ca and P from the core silica particles, to produce a stable crystalline hydroxy carbonate apatite layer deposited onto and into the dentin tubules for the immediate and long-term reduction of dentin hypersensitivity and tooth surface remineralization.
Patent NZ-332986-A (NZ)
Title: Powder paint for multilayered painting comprising at least one hydroxyl containing binder and at least one cross-linking agent having free isocyanate groups
Inventor: WONNEMANN HEINRICH
IPC: C08G18/70
Filed: 1997-04-30
Abstract: A powder paint containing at least one hydroxyl group-containing binder and at least one cross-linking agent with free isocyanate groups dispersed in the binder in the form of discrete particles with diameters of between 0.1 and 150 micrometres, in which the binder is A1) at least one hydroxyl group-containing acrylate copolymer with a glass transition temperature of 30 to 80 °C, a number average molecular weight of 2,000 to 15,000 daltons and an OH number of 60 to 180 mg KOH/g, where the hydroxyl groups of the acrylate copolymer consists of primarily bonded OH groups to the extent of over 50%, and/or A2) the reaction product of a carboxyl group-containing acrylates copolymer and an epoxide group-containing compound or the reaction product of an epoxide group-containing acrylate copolymer and a carboxyl group-containing compound, where the carboxy/epoxy reaction may take place before or during the reaction of the binder with the cross-linking agent
Patent NZ-334156-A (NZ)
Title: Hull for a sailing vessel, with open terrace deck below weather deck
Inventor: HAMATA BRUNO
IPC: B63B19/08
Filed: 1997-07-10
Abstract: A sailing vessel has a hull 1 with a continuous weather deck 2 and a low superstructure 3.   Towards the after part of the hull, there is an open terrace deck  5 beneath the weather deck.  The open sides of this deck can be closed off by roller blinds.  The terrace deck extends from amidships to the stern.
Patent NZ-337673-A (NZ)
Title: A system for purification of domestic household effluent
Inventor: BERKMAN ELIEZER
IPC: C02F3/12
Filed: 1998-03-29
Abstract: Provided is a system 10 for treatment and purification of domestic household effluent and for the elimination from the system of organic solid wastes.  The system has elements 12 and 14 for separately collecting first and second constituents of the sewage of a domestic lavatory, bath, shower, wash basin, laundry, kitchen sink sewage etc. The system contains a first and a second dual-purpose vessel 22 and 24.  Each vessel has at least one inlet port 18 and 20 and at least one outlet port 26, 28, 30, 32 and is arranged so that during the time period that one of the vessels 22 receives a first sewage constituent and acts as a collector and settling tank, the remaining vessel 24 operates as an anaerobic reaction vessel for carrying out a decomposition process.  The volume of sludge 34 contained therein is greatly reduced by conversion to compost and gas.  A gas outlet 30, 32 is provided at the top of each of the vessels.  A first valve means 16 for directing the first sewage constituent to whichever dual-purpose vessel 22, 24 is currently used as a collector and settling tank and for isolating the remaining dual-purpose vessel to convert the same to operate as an anaerobic reaction vessel.  At least one aerobic reaction vessel 40 is connected to receive an aqueous slurry containing floating organic solids from the collector and settling tank 22.  At least one aerator 42 is connected to the aerobic reaction vessel 40 for oxygenating the slurry.  A first pumping means 44, powered at least in part by gas generated in the anaerobic reaction vessel 24, is used for repeatedly driving the slurry from the aerobic reaction vessel 40 through the aerator 42.
Patent NZ-502263-A (NZ)
Title: Storage stable sustained release preparation of tramadol
Inventor: BARTHOLOMAUS JOHANNES
IPC: A61K9/26
Filed: 2000-01-11
Abstract: A process for the production of an oral, controlled release preparation of tramadol or a physiological salt thereof, having a storage stable active substance release profile, where in the active substance preparation is coated with one controlled release coating from an aqueous ethylcellulose dispersion which contains at lease one physiologically compatible, lipophilic diester of an aliphatic or aromatic dicarboxylic acid and an aliphatic alcohol as a plasticiser, and during coating, the coating is dried at product temperatures of at least 35oC , allowing a storage stable active substance release profile to be obtained without subsequent heat treatment, and in order to increase the active substance release profile without impairing the storage stability thereof, heat treatment is optionally performed at treatments of at least 35oC until the desired, increased active substance release profile is achieved.
Patent NZ-504390-A (NZ)
Title: Methylenebisphosphonic acid anhydride derivatives and pharmaceuticals thereof
Inventor: VEPSALAINEN JOUKO
IPC: A61P19/10
Filed: 1998-10-20
Abstract: The methylenebisphosphonic acid anhydride derivatives have the general formula (I), wherein: Y1, Y2, Y3 and Y4 are OR1, NR2R3, OCOR1, OCNR2R3, O(CO)OR1, O(SO2)R1, O(SO2)OR1 or OP(O)R2(OR3), wherein R1, R2 and R3 are independently H, straight or branched, optionally substituted, optionally unsaturated C1-C22 alkyl, optionally substituted, optionally unsaturated C3-C10 cycloalkyl, heterocyclyl, aryl, heteroaryl, aralkyl or silyl SiR3, wherein R means a C1-C4 alkyl, phenyl, a substituted phenyl or combinations of C1-C4 alkyls and/or phenyls, or the groups R2 and R3 together with the adjacent nitrogen atom form a 3 to 10-membered saturated, partly saturated or aromatic ring, wherein in addition to the nitrogen atom there may be one or two heteroatoms selected from the group N, O and S, or the groups R2 and R3 together with the adjacent O-PO-O group form a 5 or 6-membered ring, with the proviso that in the formula (I) at least one of the groups Y1, Y2, Y3 and Y4 is other than OR1 or NR2R3; Q1 and Q2 are independently H, F, Cl, Br or I, Stereoisomers, such as geometrical isomers and optically active isomers, of these compounds, as well as pharmacologically acceptable salts of these compounds are also described.  Pharmaceutical preparations comprising the compound of formula (I) are also described.
Patent NZ-506314-A (NZ)
Title: Dual switchpoint temperature controller with diode temperature sensor
Inventor: TENNANT JAMES A
IPC: G05D23/20
Filed: 1999-05-18
Abstract: A dual switch-point temperature control circuit switches power to a load such as a defrost heater at a first temperature (-25 degrees) and removes power from the load at a second temperature (40 degrees).  A reverse biased Schottky diode 62 circuit is biased to provide a switching signal V2 at the first temperature, and the transistor Q3 in conjunction with the diode D2 provides a feedback control circuit for adjusting the biasing of the diode temperature sensor to provide the switching signal at the second temperature.  The power switch (transistor Q2, relay 90) is coupled to the switching signal for switching power to and from the load at the respective temperatures.
Patent NZ-507233-A (NZ)
Title: Multi-layered bag and method of manufacture
Inventor: MARKHAM MICHAEL CLEMENTS
IPC: B65D30/08
Filed: 2000-10-02
Abstract: A multi layered bag and the manufacturing of the bag, which includes an inner bag located within the interior of an outer bag including a first and second region of weakness, the inner bag including a region of weakness adjacent to the outer bag's second region of weakness, wherein the inner and outer bags are sealed closed and together adjacent to the outer bags second region of weakness.
Patent NZ-508911-A (NZ)
Title: Securing electronic transactions over network stations by using encryption
Inventor: CHRISTIANSON II ALFRED
IPC: G06Q20/00
Filed: 2000-12-15
Abstract: A network system for accessing information comprises: a first network station representing a first network entity configured to control access to information stored on a network for a third network entity and to encrypt a first component message with a first crypto-key associated with the first network entity; a second network station representing a second network entity, configured to control access to the network by the third network entity, to encrypt a second component message with second  crypto-key, to combine the encrypted first and the encrypted second component message and to transmit the combined message over the network and a third network station representing the third network entity configured to receive the transmitted combined messages and to further transmit the received combined messages over the network in order to obtain access to the stored information wherein the first network station is further configured to receive the further transmitted combined messages, to decrypt the encrypted first component and the encrypted second component messages and to control access by the third network station to the stored information based on the encrypted first and second component messages. The first crypto-key can be symmetric and the second crypto-key can be a non-symmetric key. a method of creating an electronic message for transmission over a network comprises: encrypting a first component with a first crypto-key associated with a first network entity such that the encrypted first component can be decrypted by on the  first network entity; encrypting a second component with a second crypto-key associated with a second network entity such that the encrypted second component can be decrypted by the first network station and transmitting the encrypted first component and the encrypted second component as a combined message.
Patent NZ-516526-A (NZ)
Title: Glutamine obtained from a gluten protein which has undergone protease hydrolysis followed by acidification of the hydrolysate to a pH of from 4 to 5 and filtration
Inventor: MERRILL DEBRA ANN
IPC: A23J3/14
Filed: 2002-01-09
Abstract: A method is described for producing a glutamine-rich gluten-free peptide preparation from gluten protein, comprising the steps of enzymatically hydrolysing wheat gluten using one or more proteases to obtain a hydrolysate; acidifying the hydrolysate to a pH between 4 and 5; and filtering the hydrolysate to obtain the glutamine-rich gluten free peptide preparation as the filtrate.  The protease is preferably a neutral or basic protease and the optimum pH is from 4.5 to 4.7.
Patent NZ-524289-A (NZ)
Title: Delivery systems for cyclopropene compounds
Inventor: LAMOLA ANGELO ANTHONY
IPC: A01N3/00
Filed: 2003-02-20
Abstract: The application discloses a cyclopropene compound generator comprising at least one substrate, a material containing at least one cyclopropene compound and a release agent. A method of releasing at least one cyclopropene compound is also disclosed. This method comprises coating at least one side of a substrate with a material containing at least one cyclopropene compound and exposing the coated substrate to a release agent wherein a gaseous cyclopropene compound is released. A method of delivering the cyclopropene compound to a plant, fruit, flower or vegetable is also discussed.
Patent NZ-526740-A (NZ)
Title: Solid culture medium and method for preparing the same
Inventor: SOTOYAMA KAZUYOSHI
IPC: G01N33/569
Filed: 2001-08-09
Abstract: A solid medium having a 10 minute-average water absorption rate of at least 0.05 ml/minute, which is obtainable by a method for producing a solid medium comprising the steps of dissolving components of the solid medium other than solvent water into the solvent water, solidifying the obtained solution, and drying the solidified medium to remove water, wherein water is removed in such an amount that the solid medium after the removal of water should have the 10 minute-average water absorption rate of at least 0.05 ml/minute, and the amount of the solvent water is larger than a prescribed amount by an amount almost equal to the amount of the water to be removed; and a method for producing the solid medium.
Patent NZ-528284-A (NZ)
Title: Solid pharmaceutical composition comprising 4-cyano-trifluoro-3-(4-fluorophenylsulphonyl)-2-hydroxy-2-methylpropiono-m toluidide and PVP
Inventor: CAHILL JULIE KAY
IPC: A61K47/32
Filed: 2002-03-27
Abstract: A pharmaceutical formulation comprising the drug 4'-cyano-alpha',alpha',alpha'-trifluoro-3-(4-fluorophenylsulphonyl)-2-hydroxy-2-methylpropiono-m-toluidide in a solid dispersion with PVP (polyvinylpyrrolidone) is disclosed. In one embodiment, more than 50% of the drug is provided in the form of the R-enantiomer. A daily pharmaceutical dose of the drug provided by such a formulation is also provided. In addition, the use of PVP in solid dispersion with the drug (in one embodiment wherein more than 50% of the 4'-cyano-alpha',alpha',alpha'-trifluoro-3-(4-fluorophenylsulphonyl)-2-hydroxy-2-methylpropiono-m-toluidide is provided in the form of the R-enantiomer) for increasing the bioavailability of the drug; for reducing inter-patient variability in plasma concentrations of the drug; for enhancing the storage stability of the drug; or for treating and/or reducing the risk of prostate cancer in a patient is also disclosed.
Patent NZ-530741-A (NZ)
Title: Novel benzo-fused heterocycles as endothelin antagonists
Inventor: BOLLI MARTIN
IPC: A61P25/06
Filed: 2002-07-31
Abstract: Compounds of general formula I, their pharmaceutical uses and methods of manufacture are disclosed. Pharmaceutical uses include treatment of proliferative disorders which are associated with a role of endothelin.